Picture of Core Laboratories logo

CLB Core Laboratories Income Statement

0.000.00%
us flag iconLast trade - 00:00
IndustrialsAdventurousMid CapFalling Star

Annual income statement for Core Laboratories, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue668487470490510
Cost of Revenue
Gross Profit17311310296.1110
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses572564425448455
Operating Profit96.7-76.845.341.554.6
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes82-91.236.13041.2
Provision for Income Taxes
Net Income After Taxes94.3-97.120.219.737
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income102-97.619.719.536.7
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income102-97.619.719.536.7
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS2.08-0.2090.4050.4470.82
Dividends per Share